Philadelphia Pharmaceuticals Company (ASE:PHIL)
1.670
-0.010 (-0.60%)
At close: Jun 17, 2026
ASE:PHIL Market Cap
ASE:PHIL has a market cap or net worth of 12.53 million as of July 10, 2026. Its market cap has increased by 25.56% in one year.
Market Cap
12.53M
Enterprise Value
13.07M
Revenue
9.00M
Ranking
n/a
PE Ratio
12.10
Stock Price
1.67
Market Cap Chart
Since May 19, 2010, ASE:PHIL's market cap has increased from 5.22M to 12.53M, an increase of 139.94%. That is a compound annual growth rate of 5.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 12.53M | 4.38% |
| Dec 31, 2025 | 12.00M | 6.67% |
| Dec 17, 2024 | 11.25M | 4.90% |
| Dec 19, 2023 | 10.73M | 2.88% |
| Dec 15, 2022 | 10.43M | 1.46% |
| Dec 23, 2021 | 10.28M | -4.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition